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Abstract  
Aims: Although poor thymic function leading to viral and fungal infections can be a feature of 
chromosome 22q11.2 deletion syndrome, most patients have relatively normal immunity. The aim of 
this study was to investigate which clinical, as well as and laboratory parameters best predict the 
likelihood of serious or recurrent infections in patients with this syndrome. 
Methods: Clinical and laboratory parameters from 64 patients with 22q11.2 deletion syndrome 
referred to two Immunology centres in the north of England were studied retrospectively.  
Results: 31 (48%) patients had no problems with infection, 21 (33%) had bacterial infections and 12 
(19%) had recurrent or persistent thrush and/or viral enteritis and bronchiolitis, the latter suggestive 
of a significant T-cell immunodeficiency. Patients with a history of thrush/viral infections, but not 
those with bacterial infections, had significantly lower CD4+ and CD8+ T-lymphocyte numbers 
(relative risk (95% confidence interval) 0.3 (0.1 – 0.8)) and PHA mitogen responses (0.4 (0.2 – 0.8)) 
adjusted for age at testing. Hypoparathyroidism was associated with low T-lymphocyte numbers and 
function (P < 0.05) as well as an increased risk of thrush/viral infections (P < 0.0001) after adjusting 
for age at testing. 
Conclusions: 22q11.2 syndrome patients with hypoparathyroidism are more likely to have a 
clinically significant T-cell immunodeficiency and lower laboratory parameters of T-cell function, 
with a higher risk of thrush and viral bronchiolitis and enteritis. Measurement of absolute CD3 count 
is a simple and accurate predictor of fungal/viral infection risk, with PHA mitogen responses 
providing little or no further value in most patients.  
 
  
Key words: DiGeorge syndrome; 22q11.2 deletion syndrome; thymus; candidiasis; 
hypoparathyroidism 
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The 22q11.2 chromosome region consists of at least 35 genes, some of which are important in the 
development of fourth branchial arch artery structures (including the great vessels of the heart), and 
third and fourth pharyngeal pouch structures (including the thymus and parathyroid glands). Other 
genes in this region are important in the development of palatal and facial structures. Thymic 
hypoplasia leading to defective T-lymphocyte maturation is a feature of 22q11.2 deletion syndrome. 
However, recurrent candidiasis and /or severe viral infections indicative of clinically significant T-
lymphocyte dysfunction are uncommon and complete lack of T-lymphocytes associated with a 
severe combined immunodeficiency phenotype occurs in fewer than 1% of these patients.1-3 The 
heterogenous nature of this clinical syndrome makes diagnosis and prediction of the natural history a 
challenge. 
Without measuring in vitro parameters of immunity, it is currently not possible to accurately 
predict which patients with DiGeorge syndrome have T-lymphocyte dysfunction.4 Assays of T-
lymphocyte function are labour intensive and expensive. One aim of this current study was to 
determine whether in addition to assessment of absolute T-lymphocyte numbers, in vitro 
measurement of T-lymphocyte function (specifically PHA mitogen responses) is a necessary part of 
the work-up in these patients particularly as a previous study of 45 patients with Di George 
syndrome has shown that the result is usually normal.5-8 A second aim of this study was to determine 
whether the presence of specific non-immune/infection-related clinical features predicted the 
likelihood of T-lymphocyte dysfunction in patients with 22q11.2 deletion syndrome.  
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METHODS 
Patients 
Patients with 22q11.2 deletion syndrome were identified from laboratory and clinical databases 
within the two regional Clinical Immunology centres in the U.K.. Inclusion criteria were any patient 
(a) a 22q11.2 microdeletion, (b) available hospital records providing clinical details and (c) details of 
assessment of T-lymphocyte immunity by lymphocyte subset analysis and PHA mitogen responses. 
Clinical features were retrospectively collated from the review of the case notes. Adjusted plasma 
calcium and parathyroid hormone results were also noted where available. For the purposes of this 
study, patients were labelled as hypoparathyroid if they (a) had biochemical evidence of 
hypocalcaemia with or without low serum parathormone concentrations, (b) neonatal tetany or 
noctural muscle cramps that responded to calcium supplements, (c) nephrocalcinosis on renal 
ultrasound scan, or (d) severe enamel hypoplasia.  
As this was a retrospective study not involving any direct patient contact and where clinical and 
laboratory records were entered into an anonymised database, discussions with the Local Research 
Ethics Committee indicated that a formal ethics approval was not required.  
 
Measurement of T-lymphocyte numbers using flow cytometry 
Lymphocyte subsets were measured by flow cytometry using standard methodology on one 
occasion, usually at the time of diagnosis. Briefly, four colour monoclonal antibody reagents 
(CD45/CD4/CD8/CD3) and (CD45/CD56/CD19/CD3) (Reagents obtained from Beckman Coulter, 
United Kingdom) were added to whole blood. Samples were analysed on a Beckman Coulter EPICS-
XL cytometer using CD45 expression and side-scatter measurements to identify the lymphocyte cell 
population. The absolute counts of the lymphocyte subsets were determined by direct comparison 
with the Flow Count beads (Beckman Coulter, High Wycombe, United Kingdom). All bloods were 
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taken at a time when patients were free from major inter-current illness, which may have affected 
test results.  
 
Assessment of T-lymphocyte function by phytohaemagglutinin (PHA)-induced mitogenesis  
Lymphocyte transformation responses to PHA were carried out using standard methods.9 This 
involved measurement of maximal incorporation of tritiated thymidine into stimulated peripheral 
blood mononuclear cells after four days culture.  
 
Statistical analysis 
Data were analysed with SPSS 15.0 software package. (SPSS Inc, Chicago, USA). As much of the 
data were not normally distributed, non-parametric statistics were used throughout. Chi-square 
statistic is used for discrete data. Kruskal-Wallis H (groups of 3 or more) and Mann-Whitney U tests 
(comparison of two groups) were used for continuous data. Relative risk (95% confidence interval) 
for continuous variables was calculated using Cox regression analysis with “age at testing” as a 
covariate. Correlation between continuous variables was assessed using Spearman’s rho test. Data 
were considered statistical significant if P < 0.05 (2-tailed test). 
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RESULTS  
Demographic and clinical characteristics of the study cohort 
Sixty-four (74%) of the 87 patients with 22q11.2 deletion syndrome were identified between 1993 
and 2009 for whom there was a complete data set were included in the analysis. Clinical features of 
the cohort are summarised in Table I. For the purpose of analysis, patients were divided into three 
groups based on infection history. Thirty one (48%) had no significant problems with infection, 21 
(33%) had a history of recurrent bacterial ear (>3 in a 12 month period) and/or chest infections (>1 in 
a 12 month period) requiring antibiotics but no history of thrush of severe viral infections, while 12 
(19%) had a history of recurrent thrush requiring anti-fungal treatment (nine patients) and/or viral 
bronchiolitis and enteritis (six patients) requiring hospital admissions (see Table II for further 
details).  Samples for virology were not collected from patients who did not have clinical evidence of 
viral bronchiolitis or enteritis.  
19 of 57 for whom data were available had evidence of hypoparathyroidism with hypocalcaemia 
(Table I). One suffered from neonatal seizures, three from night time muscle cramps which improved 
after bed-time calcium supplementation, one had evidence of nephrocalcinosis on renal ultrasound 
and one had enamel hypoplasia. Nine had persistently low plasma calcium concentrations requiring 
calcium supplementation.  
 
Correlation between infection history and T lymphocyte numbers/function 
In thirty (47%) patients the immunology blood tests were taken at or before the age of 12 months. 
Based on published normal ranges,10 39 (61%) patients had low absolute CD3+ T-cells numbers (two 
with 100 CD3+ T-cells/microlitre indicative of a severe combined immunodeficiency), but only 4 
(6%) had lower than normal PHA mitogen responses.  
Absolute number of lymphocytes (T, B and NK cells) and PHA mitogen responses of children 
with a history of bacterial infections but no problems with thrush or viral bronchiolitis/enteritis were 
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not significantly different to children with no problems with infections (Table IIFigure 1). In 
contrast, compared with children who had no significant infection history, children with a history of 
recurrent thrush or clinically significant viral bronchiolitis and/or enteritis requiring hospital 
admission had significantly lower mean (inter-quartile range); relative risk (95% confidence 
intervals)) absolute CD4+ (475 (440 – 860) versus 1,079 (620 – 1,577);  0.3 (0.1 – 0.8)) and CD8+ 
(288 (230 – 375) versus 517 (425 – 728); 0.3 (0.1 – 0.7) T-lymphocyte numbers, as well as lower 
PHA mitogen responses (13,602 (505 – 28,066) versus 31,775 (25,094 – 51,204); 0.4 (0.2 – 0.8) 
(Table IFigure 1). CD19+ B-lymphocyte numbers were significantly higher in this group (1,987 (838 
– 2,218) versus 663 (272 – 870); 4.6 (1.2 – 16.9)). CD56+ NK-cell numbers were similar in all 
groups. Differences for absolute lymphocyte numbers and PHA mitogen responses were independent 
of the age at immune testing, determined by using this variable and clinical infection history as a 
covariate in multivariate Cox regression analysis.  
 
Correlation between infection history and other clinical parameters 
The possible association between infection history (recurrent candidiasis and/or severe viral 
infections (bronchiolitis or gastroenteritis)) indicative of suboptimal T-cell function and other 
clinical parameters were then examined (Table III). Patients with a history of these infections were 
significantly younger (median (inter-quartile range) of patients with no infections was 10 (4 – 13) 
years, those with bacterial infections only 7 (3 – 10) years, patients with additional fungal and/or 
viral bronchiolitis/gastroenteritis requiring hospital admission were 4 (1 – 6) years; p < 0.01). There 
were no significant differences in the genders of these groups. Although there was no association 
between these infections and a history of congenital heart disease or palatopharyngeal anomalies 
(diagnosed after assessment by ENT specialists), all 12 patients with recurrent fungal/severe viral 
infections had features of hypoparathyroidism, while this was only the case in 1/24 (5%) of patients 
Formatted: Font: Italic
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with no infection problems and 6/14 (32%) of patients with bacterial but no fungal/severe viral 
infections (P < 0.0001) (Figure 2).  
 
Correlation between immune function and clinical phenotype 
In view of the strong association between fungal/viral infections and features of hypoparathyroidism, 
the possible association between T-cell function and this clinical parameter was also investigated 
(Table IIIV). Compared to patients with no infection problems, those with fungal/serious viral 
infections had significantly lower absolute CD3+ T-lymphocytes (0.5 (0.3 – 0.9)) and PHA mitogen 
responses (0.4 (0.2 – 0.7), and higher CD19+ B-lymphocytes (2.6 (1.0 – 7.0)). This association was 
independent of the age at immune testing, as assessed using multi-variant analysis. There were also 
no significant differences between laboratory measures of immune function and presence or absence 
of congenital heart disease and palatopharyngeal anomalies. 
 
 
 10
DISCUSSION 
This study demonstrates for the first time the strong association between clinical features of thymic 
and parathyroid dysfunction in patients with 22q11.2 deletion syndrome. Patients with clinical/ 
subclinical hypoparathyroidism had significantly lower absolute T-lymphocyte numbers and PHA 
mitogen responses, as well as higher rates of recurrent candidiasis and severe viral infections such as 
bronchiolitis or gastroenteritis. This is in contrast to the lack of correlation between thymic 
dysfunction and congenital heart disease or palatopharygeal anomalies.  
The reasons why this specific association has not been reported previously is probably twofold. 
Firstly, the numbers of patients in previously published cohorts may have been too small to provide 
the statistical power necessary to adequately test for this association.4,6,7 Secondly, this study has 
focused on infections likely to be specifically associated with a T-lymphocyte immunodeficiency, 
namely propensity to recurrent fungal and severe viral infections, rather than grouping all bacterial, 
viral and fungal infections together. In 22q11.2 deletion syndrome, bacterial respiratory tract 
infections might relate not only to abnormalities in T-lymphocyte immunity, but also to structural 
and functional palatopharyngeal anomalies. We specifically looked for an association between 
palatopharyngeal anomalies and bacterial ear and chest infections but none was found (P = 0.3).  
The association between clinically significant thymic and parathyroid dysfunction can be 
explained by the underlying tissue field defect in the syndrome and the ontogeny of these two 
tissues. Components of both tissues are derived from the third and fourth pharyngeal pouch 
structures and thus gene defects leading to the maldevelopment of these structures would be expected 
to impact on both thymic and parathyroid function.11,12 In contrast, the primary palate is derived from 
the innermost part of the inter-maxillary segment of upper jaw. Likewise, conotruncal cardiac 
structures are not derived from the pharyngeal pouches but from adjoining branchial arch arteries, an 
anatomically distinct entity and therefore defects in genes coding for their development would be 
less likely to impact on the thymus and parathyroid glands.  
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Measurement of PHA mitogen responses added little to the measurement of absolute T-cell 
numbers, which appeared to be a more sensitive measure of thymic dysfunction. In this study, PHA 
responses were only low in patients with almost complete lack of T-lymphocytes. Low T-
lymphocyte numbers in the syndrome relate to a decrease in both CD4+ and CD8+ cells, as would be 
expected from a defect in maturation in the thymus. Another novel finding in this study was the 
increased numbers of B-lymphocytes in the subgroup of patients with poorest T-cell function. 
22q11.2 deletion syndrome is associated with an increase in autoimmune phenomena (e.g. 
autoimmune cytopenias caused by autoantibody production) particularly in older children and 
adults.1 Serum immunoglobulin concentrations and autoantibody profiles were not available in this 
cohort. Prospective studies may shed some more light on the association between subnormal T-
lymphocyte function and aberrant B-lymphocyte activity. It is possible that this may relate to 
reduced numbers of regulatory T-lymphocytes in some patients.13 
There are a number of limitations of this study. Its retrospective nature means that more direct 
laboratory measures of thymic function, for instance in terms of thymic emigrants, TRECs or Vβ 
repertoire were not examined, neither was more detailed phenotypic classification of clinical features 
such as palatopharyngeal dysfunction, which would have been interesting in relation to its effects on 
bacterial respiratory infections. More detailed, prospective studies specifically focusing on re-
evaluating some of the major findings of this study are required to better understand the genotype-
phenotype variations in this syndrome. Finally, previous studies suggest that the thymus undergoes 
maturation after infancy in some patients with 22q11.2 deletion syndrome and therefore T-
lymphocyte numbers and function taken in infancy may not reflect these parameters later in life.15 In 
order to check for potential confounding effect of age, “age of testing” was added as a covariate into 
the Cox regression analysis. This covariate did not affect the significance of the observed 
associations. 
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In summary, we have shown for the first time that in patients with 22q11.2 microdeletions, 
parathyroid insufficiency correlates strongly with low absolute T-lymphocyte numbers and an 
increased risk of severe viral/fungal infections. Low absolute T-cell numbers and PHA mitogen 
responses predict troublesome candidiasis and severe viral infections in this cohort. Measurement of 
PHA mitogen responses added little prognostic information and this test might be reserved for 
patients with the lowest absolute CD3+ T-lymphocyte counts.  
 
TAKE HOME MESSAGES 
• 22q11.2 patients with transient or persistent features of hypothyroidism are more likely to 
also have reduced T-cell numbers and PHA mitogen responses 
• This subgroup of patients is also more likely to suffer from recurrent or severe viral 
infections e.g. thrush, viral bronchiolitis and gastroenteritis 
• In general, measurement of absolute T-cell numbers provides sufficient laboratory 
information to correctly assess and manage the immunodeficiency of patients with 22q11.2 
syndrome; costly measurement of PHA mitogen responses is usually not required 
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FIGURE LEGENDS 
 
Figure 1 Box-plots showing the association between infection history and in vitro parameters of 
lymphocyte numbers and T-cell function. Panels show absolute blood CD3, CD4, CD8, CD19, CD56 
concentrations (cells/µl) and PHA mitogen responses (cpm) for patients grouped based on whether 
they had (a) no significant infections (white boxes) (n = 26), (b) bacterial infections only (light grey 
boxes) (n = 19) or (c) additional thrush and/or viral bronchiolitis/gastroenteritis (dark grey boxes) (n 
= 12) .  Boxes represent inter-quartile range with thick black line representing median. * p value < 
0.05 is for multivariate Cox regression analysis with control (no significant infections) as reference 
group and “age of test” as covariant.  
 
Figure 2  Histograms showing association between clinical parameters and infection history. White 
bars are patients without significant infections, light grey bars are those with bacterial infections only 
and dark grey bars are patients with a history of thrush and/or viral bronchiolitis/gastroenteritis 
requiring hospital admission. Numbers in the subgroup are detailed at the base of the bars. ** p value 
< 0.0001 derived from Chi-square analysis.   
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Table I Clinical and Biochemical Features of 64 children with 22q11.2 microdeletions 
Clinical parameter  
Age median (IQR) (years) 
Gender (number, percentage of males) 
Congenital heart disease (number, percentage) 
Palatopharyngeal anomalies (number, percentage) 
Hypoparathyroidism  
        number (percentage) 
        lowest adjusted plasma calcium (median (IQR) mmol/L, range 2.25 – 2.65) 
        serum parathyroid hormone (median (IQR) pg/ml, range 10 – 71) 
Infection history (number, percentage) 
        nil 
        with respiratory or deep-seated bacterial infections but no candidiasis/viral  
         gastroenteritis/bronchiolitis 
        added infections with viral gastroenteritis/bronchiolitis and/or candidiasis 
7 (3 – 11) 
34 (53%) 
51 (80%) 
12 (19%) 
 
19/57 (33%) 
1.92 (1.56 – 2.17) 
2.9 (1.8 – 10.0) 
 
31 (48%) 
 
21 (33%) 
12 (19%) 
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Table II Twelve 22q11.2 deletion syndrome patients with severe or recurrent fungal and viral 
infections  
 
Age (yrs) Fungal infections Viral infections Microbiology 
1 recurrent oral candidiasis severe bronchiolitis 
requiring ventilation 
candida (mouth), RSV (NPA) 
1 nil protracted enteritis norovirus (stools) 
1 recurrent oral candidiasis nil candida (mouth) 
2 recurrent oral/perineal 
candidiasis 
nil candida (mouth, perineum) 
3 nil severe bronchiolitis 
requiring ventilation 
RSV (NPA) 
5 recurrent oral/perineal 
candidiasis 
protracted enteritis for 
first 18 months of life  
candida (perineum), 
adenovirus + SRSV (stools) 
5 recurrent oral candidiasis nil candida (mouth) 
5 recurrent oral candidiasis nil candida (mouth) 
7 recurrent oral/perineal 
candidiasis 
protracted enteritis candida (mouth, perineum), 
adenovirus (stools) 
8 recurrent oral candidiasis nil candida (mouth) 
9 nil bronchiolitis X 2, 
chickenpox X 4 
RSV (NPA) 
9 oral candidiasis throughout 
preschool years 
nil candida (mouth) 
 RSV = respiratory syncytial virus, NPA = nasopharyngeal aspirate, SRSV = small round structured 
virus
Formatted: Font: Bold
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 Table II Association between Infection History and in vitro Parameters of Lymphocyte 
Numbers and T-cell Function 
 No significant infection 
n = 26 
 + bacterial only 
n = 19 
+ viral/fungal 
n = 12 
age at test (months) † 
 
12 (3 – 47) 23 (13 – 42) 8 (1 – 20) 
absolute CD3 (X 10^9/L) † 
 
1,575 (1,181 – 1,975) 1,276 (920 – 1,590) 
 
0.7 (0.4 – 1.4) 
 
730 (355 – 1,330)  
 
0.7 (0.4 – 1.4) 
 
absolute CD4 (X 10^9/L) 
 
1,079 (620 – 1,577) 721 (552 – 1,028) 
 
0.6 (0.3 – 1.4) 
 
475 (440 – 860) 
 
0.3 (0.1 – 0.8)* 
 
absolute CD8 (X 10^9/L) † 
 
517 (425 – 728) 475 (313 – 757) 
 
0.8 (0.4 – 1.7) 
 
288 (230 – 375) 
 
0.3 (0.1 – 0.8)* 
 
absolute CD19 (X 10^9/L) 
 
663 (272 – 870) 592 (460 – 1,159) 
 
1.0 (0.4 – 2.1) 
 
1,987 (838 – 2,218) 
 
4.6 (1.2 – 16.9)* 
 
absolute CD56 (X 10^9/L) 
 
316 (199 – 602) 580 (378 – 608) 
 
1.3 (0.3 – 4.7) 
 
263 (254 – 1,125) 
 
0.9 (0.2 – 4.8) 
 
PHA induced mitogenesis 
(cpm) † 
  
31,775 (25,094 – 51,204) 29,379 (24,519 – 36,929) 
 
0.9 (0.5 – 1.9) 
 
13,602 (505 – 28,066) 
 
0.4 (0.2 – 0.8)* 
 
 
Median (inter-quartile range) † P value < 0.05 by Kruskal-Wallis test;  / relative risk (95% confidence 
intervals). * P value < 0.05 is for multivariate Cox regression analysis with control (no infections) as 
reference group and “age of test” as co-variant.  
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Table III Association between Clinical Parameters and Infection History  
 no infection bacterial only 
 
+ fungal/viral P value 
Age (years) 
Median (IQR) 
 
 
10 (4 – 13) 
 
7 (3 – 10) 
 
4 (1 – 6) 
 
0.01 
Gender 
Male    n = 34 
Female n = 30 
 
 
18 (53%) 
13 (43%) 
 
11 (32%) 
10 (33%) 
 
5 (15%) 
7 (23%) 
 
 
0.6 
Cardiac anomalies 
Absent n = 13 
Present n = 51 
 
 
7 (54%) 
24 (47%) 
 
5 (39%) 
16 (31%) 
 
1 (7%) 
11 (22%) 
 
 
0.5 
 
Palatopharyngeal 
anomalies  
Absent n = 52 
Present n = 12 
 
 
 
27 (52%) 
4 (33%) 
 
 
16 (31%) 
5 (42%) 
 
 
9 (17%) 
3 (25%) 
 
 
 
0.5 
Hypoparathyroidism 
Absent n = 38 
Present n = 19 
 
 
24 (63%) 
1 (5%) 
 
14 (37%) 
6 (32%) 
 
0 (0%) 
12 (63%) 
 
 
0.0001 
Table III  
P value derived from Chi-Square analysis, or for age Kruskal-Wallis Test. 
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Table IV Association between Clinical and Immune Parameters  
 Congenital heart disease 
No  n = 13 
Yes n = 44 
Palatopharyngeal  
No  n = 45 
Yes n = 12 
Hypoparathyroidism 
No  n = 35 
Yes n = 19 
Abs CD3 1,276 (951 – 2,060) 
1,320 (836 – 1,825) 
 
1.2 (0.6 – 2.4) 
 
1,310 (902 – 1,876) 
1,285 (773 – 2,015) 
 
0.9 (0.5 – 1.7) 
 
1,430 (1,220 – 2,020) 
820 (600 – 1,410) † 
 
0.5 (0.3 – 0.9)* 
 
Abs CD4 663 (521 – 1,463) 
860 (551 – 1,166) 
 
1.4 (0.6 – 3.9) 
 
709 (550 – 1,082) 
871 (578 – 1,657) 
 
1.7 (0.8 – 3.8) 
 
1,007 (556 – 1,566) 
512 (428 – 860) † 
 
0.3 (0.1 – 0.7)* 
 
Abs CD8 435 (304 – 743) 
463 (289 – 678) 
 
1.7 (0.7 – 4.6) 
 
517 (288 – 686) 
400 (318 – 752) 
 
1.0 (0.5 – 2.2) 
 
675 (456 – 813) 
290 (217 – 550) † 
 
0.3 (0.1 – 0.7)* 
 
Abs CD19 824 (495 – 1,351) 
680 (412 – 1,000) 
 
1.0 (0.4 – 2.7) 
 
673 (456 – 1,043) 
680 (449 – 950) 
 
0.9 (0.4 – 1.9) 
 
675 (456 – 870) 
980 (462 – 1,987) † 
 
2.6 (1.0 – 7.0)* 
 
Abs CD56 
 
397 (354 – 440) 
348 (236 – 612) 
 
1.0 (0.1 – 7.7) 
 
354 (215 – 608) 
378 (284 – 860) 
 
1.2 (0.5 –3.6) 
 
378 (243 – 608) 
263 (213 – 782) 
 
0.9 (0.3 – 2.7) 
 
PHA 31,814 (23,520 – 42,456) 
28,802 (20,377 – 39,868) 
 
1.0 (0.4 – 2.2) 
 
29,167 (23651 – 52449) 
33,245 (19335 – 45747) 
 
1.0 (0.5 – 2.0) 
 
33,245 (28,808 – 46,492) 
24,186 (6,882 – 33,419) † 
 
0.4 (0.2 – 0.7)* 
 
age at test 10 (5 – 24) 
15 (5 – 45) 
14 (5 – 45) 
17 (8 – 24) 
15 (9 – 51) 
10 (3 – 27) 
 
Absolute (Abs) cell count is given as cells x 109/L, PHA mitogen response as cpm, age at test as months. 
Median (inter-quartile range) † P value < 0.05 by Mann-Whitney U test;  / relative risk (95% confidence 
intervals). * P value < 0.05 is for multivariate Cox regression analysis with control (no infections) as 
reference group and “age of test” as co-variant.  
 
